Skip to main content
Log in

The association between clinically relevant anxiety and other non-motor symptoms in Parkinson’s disease

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Anxiety disorders in patients with Parkinson’s disease (PD) are often missed due to an overlap with other non-motor symptoms. The relationships between anxiety and other non-motor symptoms in PD still remain unclear. We used the Hamilton anxiety rating scale and the Non-motor Symptoms Questionnaire to measure anxiety and the complex range of non-motor symptoms in 99 PD patients. The relationships between anxiety and other PD-related non-motor symptoms were examined through regression analyses. 25 % of PD patients were diagnosed with clinically relevant anxiety. Non-motor symptoms were more prominent in patients with anxiety. Depression, urinary disorders, and sleep disruption were the factors most likely to influence anxiety in PD. Our findings have revealed a strong interplay between anxiety and other non-motor symptoms of PD and have highlighted the need for a holistic approach towards the clinical treatment of this disabling condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Soh SE, Morris ME, McGinley JL (2011) Determinants of health-related quality of life in Parkinson’s disease: a systematic review. Parkinsonism Relat Disord 17:1–9

    Article  PubMed  Google Scholar 

  2. Chen JJ, Marsh L (2014) Anxiety in Parkinson’s disease identification and management. Ther Adv Neurol Disord 7:52–59

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Dissanayaka NN, White E, O’Sullivan JD et al (2014) The clinical spectrum of anxiety in Parkinson’s disease. Mov Disord 29:967–975

    Article  PubMed  Google Scholar 

  4. Pontone GM, Williams JR, Anderson KE et al (2009) Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson’s disease. Mov Disord 24:1333–1338

    Article  PubMed Central  PubMed  Google Scholar 

  5. Shulman LM, Taback RL, Rabinstein AA et al (2002) Non-recognition of depression and other non-motor symptoms in Parkinson’s disease. Parkinsonism Relat Disord 8:193–197

    Article  CAS  PubMed  Google Scholar 

  6. Vazquez A, Jimenez-Jimenez FJ, Garcia-Ruiz P et al (1993) “Panic attacks” in Parkinson’s disease. A long-term complication of levodopa therapy. Acta Neurol Scand 87:14–18

    Article  CAS  PubMed  Google Scholar 

  7. Lauterbach EC, Freeman A, Vogel RL (2003) Correlates of generalized anxiety and panic attacks in dystonia and Parkinson disease. Cogn Behav Neurol 16:225–233

    Article  PubMed  Google Scholar 

  8. Rutten S, Ghielen I, Vriend C et al (2015) Anxiety in Parkinson’s disease: symptom dimensions and overlap with depression and autonomic failure. Parkinsonism Relat Disord 21:189–193

    Article  PubMed  Google Scholar 

  9. Hughes AJ, Daniel SE, Kilford L et al (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442

    Article  CAS  PubMed  Google Scholar 

  11. Fahn S (2005) Does levodopa slow or hasten the rate of progression of Parkinson’s disease? J Neurol 252 (suppl 4):IV37–IV42

  12. Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198

    Article  CAS  PubMed  Google Scholar 

  13. Wenzelburger R, Zhang B, Pohle S (2002) Force overflow and levodopa-induced dyskinesias in Parkinson’s disease. Brain 125:871–879

    Article  PubMed  Google Scholar 

  14. Leentjens AF, Dujardin K, Marsh L et al (2010) Anxiety rating scales in Parkinson’s disease: a validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale. Mov Disord 26:407–415

    Article  Google Scholar 

  15. Chaudhuri KR, Martinez-Martin P, Schapira AH et al (2006) International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord 21:916–923

    Article  PubMed  Google Scholar 

  16. Jack M, Gorman MD (1996) Comorbid depression and anxiety spectrum disorders. Depress Anxiety 4:160–168

    Article  Google Scholar 

  17. Yamanishi T, Tachibana H, Oguru M et al (2013) Anxiety and Depression in Patients with Parkinson’s Disease. Intern Med 52:539–545

    Article  PubMed  Google Scholar 

  18. Kano O, Ikeda K, Cridebring D et al (2011) Neurobiology of depression and anxiety in Parkinson’s disease. Parkinson’s Disease 2011:143547–143551

    PubMed Central  PubMed  Google Scholar 

  19. Leentjens AF, Dujardin K, Marsh L et al (2011) Symptomatology and markers of anxiety disorders in Parkinson’s disease: a cross-sectional study. Mov Disord 26:484–492

    Article  PubMed  Google Scholar 

  20. De Luka SR, Svetel M, Pekmezovic T et al (2014) When do the symptoms of autonomic nervous system malfunction appear in patients with Parkinson’s disease? Vojnosanit Pregl 71:346–351

    Article  PubMed  Google Scholar 

  21. Burnum JF, Hickam JB, Mc IH (1954) The effect of hypocapnia on arterial blood pressure. Circulation 9:89–95

    Article  CAS  PubMed  Google Scholar 

  22. Berrios GE, Campbell C, Politynska BE (1995) Autonomic failure, depression and anxiety in Parkinson’s disease. Br J Psychiatry 166:789–792

    Article  CAS  PubMed  Google Scholar 

  23. Borek LL, Kohn R, Friedman JH (2006) Mood and sleep in Parkinson’s disease. J Clin Psychiatry 67:958–963

    Article  PubMed  Google Scholar 

  24. Leentjens AF, Dujardin K, Marsh L et al (2008) Anxiety rating scales in Parkinson’s disease:critique and recommendations. Mov Disord 23:2015–2025

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the Natural science foundation of Jiangsu Province (No. BK20141494), the Jiangsu Provincial Personnel Department “the Great of Six Talented Man Peak” Project (No. 2014-WSN-013), the University Natural Science Research Project in Jiangsu Province (No. 13KJB32009), the Opening Project of Jiangsu Key Laboratory of Neurodegeneration (No. SJ11KF01), and Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ke-Zhong Zhang.

Ethics declarations

The authors declare that they have no conflict of interest.

Additional information

S.-M. Jiang, Y.-S. Yuan and Q. Tong contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jiang, SM., Yuan, YS., Tong, Q. et al. The association between clinically relevant anxiety and other non-motor symptoms in Parkinson’s disease. Neurol Sci 36, 2105–2109 (2015). https://doi.org/10.1007/s10072-015-2320-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-015-2320-0

Keywords

Navigation